Acute Kidney Injury in a Case Series of Patients with Confirmed COVID-19 (Coronavirus Disease 2019): Role of Angiotensin-Converting Enzyme 2 and Renin-Angiotensin System Blockade

The renin-angiotensin system plays a very critical role in hypertension, diabetes, and kidney and heart diseases. The blockade of the renin-angiotensin system results in the prevention of progression of renal and cardiac damage. There have been controversial hypotheses raised regarding the safety of...

Full description

Saved in:
Bibliographic Details
Main Authors: Avantika Chenna, Venu Madhav Konala, Subhasish Bose, Sasmit Roy, Bhaskar Reddy Madhira, Vijay Gayam, Srikanth Naramala, Sreedhar Adapa
Format: Article
Language:English
Published: Wiley 2020-01-01
Series:Case Reports in Nephrology
Online Access:http://dx.doi.org/10.1155/2020/8811931
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832546899042762752
author Avantika Chenna
Venu Madhav Konala
Subhasish Bose
Sasmit Roy
Bhaskar Reddy Madhira
Vijay Gayam
Srikanth Naramala
Sreedhar Adapa
author_facet Avantika Chenna
Venu Madhav Konala
Subhasish Bose
Sasmit Roy
Bhaskar Reddy Madhira
Vijay Gayam
Srikanth Naramala
Sreedhar Adapa
author_sort Avantika Chenna
collection DOAJ
description The renin-angiotensin system plays a very critical role in hypertension, diabetes, and kidney and heart diseases. The blockade of the renin-angiotensin system results in the prevention of progression of renal and cardiac damage. There have been controversial hypotheses raised regarding the safety of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in COVID-19 (coronavirus disease 2019). We present the case series of four patients (2 men and 2 women; 1 Caucasian and 3 African Americans; two survived and two died) with confirmed COVID-19, presenting with respiratory symptoms and acute kidney injury, who have been on angiotensin-converting enzyme inhibitors or angiotensin receptor blockers. Membrane-bound angiotensin-converting enzyme 2 (ACE2) has been implicated as the gateway for viral entry into the human cell in causing the infection. The factors contributing to acute kidney injury are diuretics, iodinated contrast administration, hemodynamic instability apart from ACE inhibitors, and angiotensin receptor blockers. The ACE inhibitors and ARBs were stopped in these patients due to acute kidney injury. We also discussed the role of ACE2 and the renin-angiotensin system (RAS) blockade in patients with COVID-19 infection along with pathogenesis.
format Article
id doaj-art-b5b371f5b67142e4b9ba8a85c7f137e6
institution Kabale University
issn 2090-6641
2090-665X
language English
publishDate 2020-01-01
publisher Wiley
record_format Article
series Case Reports in Nephrology
spelling doaj-art-b5b371f5b67142e4b9ba8a85c7f137e62025-02-03T06:46:55ZengWileyCase Reports in Nephrology2090-66412090-665X2020-01-01202010.1155/2020/88119318811931Acute Kidney Injury in a Case Series of Patients with Confirmed COVID-19 (Coronavirus Disease 2019): Role of Angiotensin-Converting Enzyme 2 and Renin-Angiotensin System BlockadeAvantika Chenna0Venu Madhav Konala1Subhasish Bose2Sasmit Roy3Bhaskar Reddy Madhira4Vijay Gayam5Srikanth Naramala6Sreedhar Adapa7Department of Internal Medicine, Division of Nephrology, Phobe Putney Memorial Hospital, Medical College of Georgia, 417 W 3rd Avenue, Albany 31701, GA, USADepartment of Internal Medicine, Division of Medical Oncology, Ashland Bellefonte Cancer Center, 122 St Christopher Dr, Ashland 41169, KY, USALynchburg Nephrology Physicians, Lynchburg, VA, USALynchburg Nephrology Physicians, Lynchburg, VA, USAFellow in Hematology and Oncology, Sunny Upstate Medical University, Syracuse, NY, USADepartment of Medicine, Interfaith Medical Center, Brooklyn, NY, USADepartment of Internal Medicine, Division of Rheumatology, Adventist Medical Center, Hanford 93230, CA, USADepartment of Internal Medicine, Division of Nephrology, Adventist Medical Center, Hanford 93230, CA, USAThe renin-angiotensin system plays a very critical role in hypertension, diabetes, and kidney and heart diseases. The blockade of the renin-angiotensin system results in the prevention of progression of renal and cardiac damage. There have been controversial hypotheses raised regarding the safety of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in COVID-19 (coronavirus disease 2019). We present the case series of four patients (2 men and 2 women; 1 Caucasian and 3 African Americans; two survived and two died) with confirmed COVID-19, presenting with respiratory symptoms and acute kidney injury, who have been on angiotensin-converting enzyme inhibitors or angiotensin receptor blockers. Membrane-bound angiotensin-converting enzyme 2 (ACE2) has been implicated as the gateway for viral entry into the human cell in causing the infection. The factors contributing to acute kidney injury are diuretics, iodinated contrast administration, hemodynamic instability apart from ACE inhibitors, and angiotensin receptor blockers. The ACE inhibitors and ARBs were stopped in these patients due to acute kidney injury. We also discussed the role of ACE2 and the renin-angiotensin system (RAS) blockade in patients with COVID-19 infection along with pathogenesis.http://dx.doi.org/10.1155/2020/8811931
spellingShingle Avantika Chenna
Venu Madhav Konala
Subhasish Bose
Sasmit Roy
Bhaskar Reddy Madhira
Vijay Gayam
Srikanth Naramala
Sreedhar Adapa
Acute Kidney Injury in a Case Series of Patients with Confirmed COVID-19 (Coronavirus Disease 2019): Role of Angiotensin-Converting Enzyme 2 and Renin-Angiotensin System Blockade
Case Reports in Nephrology
title Acute Kidney Injury in a Case Series of Patients with Confirmed COVID-19 (Coronavirus Disease 2019): Role of Angiotensin-Converting Enzyme 2 and Renin-Angiotensin System Blockade
title_full Acute Kidney Injury in a Case Series of Patients with Confirmed COVID-19 (Coronavirus Disease 2019): Role of Angiotensin-Converting Enzyme 2 and Renin-Angiotensin System Blockade
title_fullStr Acute Kidney Injury in a Case Series of Patients with Confirmed COVID-19 (Coronavirus Disease 2019): Role of Angiotensin-Converting Enzyme 2 and Renin-Angiotensin System Blockade
title_full_unstemmed Acute Kidney Injury in a Case Series of Patients with Confirmed COVID-19 (Coronavirus Disease 2019): Role of Angiotensin-Converting Enzyme 2 and Renin-Angiotensin System Blockade
title_short Acute Kidney Injury in a Case Series of Patients with Confirmed COVID-19 (Coronavirus Disease 2019): Role of Angiotensin-Converting Enzyme 2 and Renin-Angiotensin System Blockade
title_sort acute kidney injury in a case series of patients with confirmed covid 19 coronavirus disease 2019 role of angiotensin converting enzyme 2 and renin angiotensin system blockade
url http://dx.doi.org/10.1155/2020/8811931
work_keys_str_mv AT avantikachenna acutekidneyinjuryinacaseseriesofpatientswithconfirmedcovid19coronavirusdisease2019roleofangiotensinconvertingenzyme2andreninangiotensinsystemblockade
AT venumadhavkonala acutekidneyinjuryinacaseseriesofpatientswithconfirmedcovid19coronavirusdisease2019roleofangiotensinconvertingenzyme2andreninangiotensinsystemblockade
AT subhasishbose acutekidneyinjuryinacaseseriesofpatientswithconfirmedcovid19coronavirusdisease2019roleofangiotensinconvertingenzyme2andreninangiotensinsystemblockade
AT sasmitroy acutekidneyinjuryinacaseseriesofpatientswithconfirmedcovid19coronavirusdisease2019roleofangiotensinconvertingenzyme2andreninangiotensinsystemblockade
AT bhaskarreddymadhira acutekidneyinjuryinacaseseriesofpatientswithconfirmedcovid19coronavirusdisease2019roleofangiotensinconvertingenzyme2andreninangiotensinsystemblockade
AT vijaygayam acutekidneyinjuryinacaseseriesofpatientswithconfirmedcovid19coronavirusdisease2019roleofangiotensinconvertingenzyme2andreninangiotensinsystemblockade
AT srikanthnaramala acutekidneyinjuryinacaseseriesofpatientswithconfirmedcovid19coronavirusdisease2019roleofangiotensinconvertingenzyme2andreninangiotensinsystemblockade
AT sreedharadapa acutekidneyinjuryinacaseseriesofpatientswithconfirmedcovid19coronavirusdisease2019roleofangiotensinconvertingenzyme2andreninangiotensinsystemblockade